Answers are grounded in this paper and cite their sources.
Germline genetic testing is a vital component of guideline-recommended cancer care for males with pancreatic, breast, or metastatic prostate cancers. We sought to determine whether there were racial disparities in germline genetic testing completion in this population.
No takes yet. Share an insight, caveat, or question.
Shevach et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: